ESOPREVEG DSR

ESOPREVEG DSR Capsules combine Esomeprazole 40 mg, a proton pump inhibitor (PPI), with Domperidone 30 mg (Sustained Release), a prokinetic agent, to provide effective relief from acid reflux, gastroesophageal reflux disease (GERD), acidity, heartburn, and dyspepsia. This dual-action formulation reduces excess stomach acid production while improving gastric motility, helping relieve symptoms such as acid regurgitation, nausea, bloating, and indigestion.

ESOPREVEG DSR offers long-lasting relief from acid-related disorders and promotes better digestive comfort by addressing both acid secretion and delayed stomach emptying.

Key Benefits

• Provides effective relief from acidity and heartburn
• Helps manage GERD (Gastroesophageal Reflux Disease)
• Reduces excess stomach acid production
• Improves gastric emptying and digestive motility
• Relieves nausea, bloating, and acid regurgitation
• Promotes long-lasting digestive comfort